Health Economic Assessment of Tygacil® in the Treatment of Secondary Peritonitis in Intensive Care Units (ICUs)

Wyeth

Status: Completed

Conditions: Peritonitis

Treatments: Drug: Tygacil

Study type: Observational

Funder types: Industry

Identifiers

NCT00481962

3074A1-102184

Details and patient eligibility

About

The main goals of the study are: Assessment of Tygacil's cost-effectiveness; Process cost analysis from a hospital perspective (including length of stay, treatment costs, side effect management costs, costs of monitoring, costs of diagnostic procedures, cost of care (TISS 10 score etc.); Efficacy of Tygacil under usual care conditions (cure rate).

Enrollment: 180 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Diagnosis of secondary peritonitis
• Treatment in an ICU
• Patient age >18 years